APA (7th ed.) Citation

Farnie, G., Willan, P. M., Clarke, R. B., & Bundred, N. J. Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Farnie, Gillian, Pamela M. Willan, Robert B. Clarke, and Nigel J. Bundred. Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma in Situ (DCIS) Stem/progenitor Cell Activity Regardless of ErbB2 Status. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Farnie, Gillian, et al. Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma in Situ (DCIS) Stem/progenitor Cell Activity Regardless of ErbB2 Status. Public Library of Science (PLoS).